A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia

被引：0
|
作者：
Saleh, MN
Gutheil, J
Moore, M
Bunch, PW
Butler, J
Kunkel, L
Grillo-López, AJ
LoBuglio, AF
机构：
[1] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[2] Genentech Inc, S San Francisco, CA 94080 USA
[3] Georgia Canc Specialists, Atlanta, GA USA
[4] Sidney Kimmel Canc Ctr, San Diego, CA USA
[5] IDEC Pharmaceut Corp, San Diego, CA USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99 / 103
页数：5
相关论文
共 50 条
  • [41] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
    Brændstrup, P
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 275 - 280
  • [42] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
  • [43] Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia
    Kerridge, I
    Hann, I
    Ethel, M
    Potter, M
    Prentice, HG
    INTERNAL MEDICINE JOURNAL, 2003, 33 (11) : 544 - U3
  • [44] Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus
    Lee, J-W
    Kim, H-A
    Sung, J-M
    Suh, C-H
    LUPUS, 2010, 19 (02) : 227 - 228
  • [45] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [46] Anti-cd20 monoclonal antibody treatment (rituximab) in acute lymphoblastic leukemia
    Jándula, BM
    Nomdedeu, J
    Marín, P
    Muñoz, L
    Vivancos, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S92 - S92
  • [47] Rituximab (anti-CD20 monoclonal antibody) - Ultimate or first choice in pemphigus?
    Hertl, Michael
    Eming, Ruediger
    Borradori, Luca
    DERMATOLOGY, 2007, 214 (04) : 275 - 277
  • [48] An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
    Boye, J
    Elter, T
    Engert, A
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 520 - 535
  • [49] Treatment of Cutaneous Lymphoid Hyperplasia with the Monoclonal Anti-CD20 Antibody Rituximab
    Martin, Stephanie J.
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03): : 286 - 288
  • [50] Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
    Iwata, S.
    Saito, K.
    Hirata, S.
    Ohkubo, N.
    Nakayamada, S.
    Nakano, K.
    Hanami, K.
    Kubo, S.
    Miyagawa, I.
    Yoshikawa, M.
    Miyazaki, Y.
    Yoshinari, H.
    Tanaka, Y.
    LUPUS, 2018, 27 (05) : 802 - 811
12345